CV (cardiovascular) device incubator looking to create 6 new companies - update
This article was originally published in Clinica
Executive Summary
Up to six new companies will be created to develop cardiovascular devices under the aegis of Accelerated Technologies Inc (ATI), a New York-based medtech incubator. ATI has just raised $32m in venture financing in equal parts from venture capital firms US-based Oxford Bioscience Partners, Dutch ABN AMRO Capital and Giza Venture Capital (Israel).